IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors-Reference-Cited by-同舟云学术

IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors

Published:2018-01-16 Issue:7 Volume:24 Page:1705-1715
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Molenaar Remco J.,Radivoyevitch Tomas,Nagata Yasunobu,Khurshed Mohammed,Przychodzen Bartolomiej,Makishima Hideki,Xu Mingjiang,Bleeker Fonnet E.,Wilmink Johanna W.,Carraway Hetty E.,Mukherjee Sudipto,Sekeres Mikkael A.,van Noorden Cornelis J.F.,Maciejewski Jaroslaw P.

Funder

KWF Kankerbestrijding (Dutch Cancer Society)

HHS | National Institutes of Health (NIH)

Aplastic Anemia and MDS International Foundation (AA&MDSIF)

Robert Duggan Charitable Fund

Scott Hamilton CARES

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiosensitizing Effect of PARP Inhibition on Chondrosarcoma and Chondrocyte Cells Is Dependent on Radiation LET;Biomolecules;2024-08-27

2. Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia;Frontiers in Pharmacology;2024-08-08

3. DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies;Blood;2024-05-23

4. Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-05

5. High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response;Journal of Molecular Medicine;2024-02-10